The GBD 2021 Adolescent BMI Collaborators concluded that global efforts over the past three decades have failed to adequately address the obesity crisis in children and adolescents. Consequently ...

Obesity and stress could magnify the risk of one of the most aggressive types of cancer, a new study suggests. Researchers at University of California Los Angeles (UCLA) found that stress-related ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The head of the obesity programme at the world’s largest philanthropic organisation, the Novo Nordisk ...

Research shows that these ultra-processed, high-calorie foods play a significant role in the development of obesity, but the lasting effects these foods have on the brain was not clear – until now.

Obesity is a growing health concern worldwide, affecting millions of people. It not only impacts physical appearance but also increases the risk of several chronic diseases, including diabetes, heart ...

Obesity in women is a significant public health issue with serious implications for cardiovascular-kidney-metabolic syndrome and cardiovascular disease. This complex challenge is influenced by ...

China’s Harbour BioMed has launched a new biotech to develop bispecific antibodies focused on the holy grail of next-gen obesity meds—reducing body weight without losing muscle mass.

Shares in Novo Nordisk fell on Monday on a second set of worse than expected trial results for the latest obesity drug from the manufacturer of blockbuster treatments Ozempic and Wegovy.

A new study claims there are two kinds of obesity – one of which puts you at risk of major health problems. Find out which camp you’re in ...

LONDON/COPENHAGEN, March 10 (Reuters) - Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares and ...

Ms Mishlawi said the current medicines were “only the beginning” because there are so many new obesity drugs being developed. Some US health insurers and many European healthcare systems are ...